Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings,…
Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and…
PR Newswire is a distributor of press releases headquartered in New York City.